Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study (NCT07146412)
๐ฉบ Plain-English Summary (8th-Grade Level)
Many individuals develop dementia, and dementia has multiple causes, yet we currently have limited treatment options. A critical observation of the effectiveness of the available dementia treatments is that they tend to be more effective when started early. Previous studies have shown that multimodal lifestyle interventions can significantly delay the onset of Alzheimer's dementia in individuals with high risk for Alzheimer's or with Mild Cognitive Impairment (MCI). These interventions may be less effective when initiated after dementia has already been diagnosed or is more advanced. This study has two primary goals. The first goal is to assess attitudes around dementia risk for participants throughout the study as they learn of their personalized risk and possible lifestyle factors that may modify that risk. The second goal is to serve as a logistical pilot for the implementation of data collection and processing and multimodal lifestyle intervention to reduce the risk factors of dementia in individuals without current cognitive impairment but who are at high risk of progression to dementia. Secondary goals of this study include better defining what factors contribute the most risk to dementia and identifying sub-types of dementia defined by different genetic and molecular risk factors.
Who can join: Review the eligibility criteria below.
Location: Smith Family Clinic for Genomic Medicine โ Huntsville, Alabama
Age range: 65 Years to 75 Years
๐งช Interventions in This Study
- Multimodal Lifestyle Intervention (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Smith Family Clinic for Genomic Medicine โ Huntsville, Alabama
๐ Contact the Study Coordinator
Phone: (256) 327-5262
Email: ncochran@hudsonalpha.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cognitive Impairment
- The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition โ Salt Lake City, Utah
- Cognitive Screening Made Easy for PCPs - R33 Phase โ Austin, Texas
- Anticipating Decline and Providing Therapy โ Winston-Salem, North Carolina
- Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium โ Los Angeles, California
- COgnitive and Physical Exercise to Improve Outcomes After Surgery (COPE-iOS) Study โ Nashville, Tennessee
- The Care for America's Aging Study โ Boston, Massachusetts
Explore by condition: All Cognitive Impairment clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.